In vitro activity of a new pneumocandin antifungal, L-743,872, against azole-susceptible and -resistant Candida species

Antimicrobial Agents and Chemotherapy

Volumn 41, Issue 7, 1997, Pages 1612-1614

  Vazquez, Jose A ^a,b,c   Lynch, Maria ^a   Boikov, Dina ^a   Sobel, Jack D ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Departments of Infectious Disease   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; KETOCONAZOLE; PNEUMOCANDIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDIASIS; DRUG SENSITIVITY; FUNGICIDAL ACTIVITY; NONHUMAN; PRIORITY JOURNAL; STRAIN DIFFERENCE;

EID: 0030757452     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.41.7.1612     Document Type: Article

References (11)

1. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, W. J. Martone, and the National Nosocomial Infections Surveillance System. 1991. Secular trends in nosocomial primary blood stream infections in the United States. Am. J. Med. 91(Suppl. 3B):86S-89S.
2. Beck-Sague, C. M., T. R. Jarvis, and the National Nosocomial Infections Surveillance System. 1991. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. J. Infect. Dis. 167:1247-1251.
3. Bodey, G. P. 1986. Candidiasis in cancer patients. Am. J. Med. 77:(Suppl. 4D):13-19.
4. 0 derivatives. J. Med. Chem. 37:222-225.
5. Cabib, E., and M. S. Kang. 1987. Fungal 1,3-β-glucan synthase. Methods Enzymol. 138:637-642.
6. Cassone, A., R. E. Mason, and D. Kerridge. 1981. Lysis of growing yeast-form cells of Candida albicans by echinocandin; a cytological study. Sabouraudia 19:97-110.
7. Espinel-Ingroff, A., C. S. Kish, T. M. Kerkering, R. A. Fromtling, K. Bartizal, J. N. Galgiani, K. Villareal, M. A. Pfaller, T. Gerarden, M. G. Rinaldi, and A. Fothergill. 1992. Collaborative comparison of macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30:3138-3145.
8. Sawistoska-Schroder, E. T., D. Kerridge, and H. Perry. 1984. Echinocandin inhibition of 1,3-β-glucan synthase from Candida albicans. FEBS Lett. 173: 134-138.
9. Shadomy, S., and M. A. Pfaller. 1991. Laboratory studies with antifungal agents: susceptibility tests and quantitation in body fluids, p. 1173-1183. In A. Balows, W. J. Hausler, Jr., K. L. Herrmann, H. D. Isenberg, and H. J. Shadomy (ed.), Manual of clinical microbiology, 5th ed. American Society for Microbiology, Washington, D.C.
10. Warnock, D., J. Burke, N. J. Cope, E. Johnson, N. Von Fraunhofer, and E. Williams. 1988. Fluconazole resistance in Candida glabrata. Lancet i:1310.
11. Wingard, J. R., W. G. Merz, M. G. Rinaldi, T. R. Johnson, J. E. Karp, and R. Saral. 1991. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole. N. Engl. J. Med. 18:1274-1277.